EURURO Vol. 71 No. 5

Previous Page

Next Page

Page Background

837

Percutaneous Nephrolithotomy: Update, Trends, and Future Directions for Simultaneous Supine Percutaneous Nephrolithotomy and Retrograde Ureterolithotripsy in the Galdakao-modified Supine Valdivia Position for Large Proximal Ureteral Calculi

T.-Y. Huang, K.M. Feng, I.-S. Lo

838

How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer?

F. Seyednasrollah, M. Mahmoudian, L. Rautakorpi, O. Hirvonen, T. Laitinen, S. Jyrkkiö, L.L. Elo

840

Methodological Considerations for Early-phase Development of Immune Checkpoint Inhibitors in Urothelial Bladder Cancer

A. Necchi, D. Giardiello, L. Mariani

841

Mutagenic Factors and Complex Clonal Relationship of Multifocal Urothelial Cell Carcinoma

Y. Du, R. Li, Z. Chen, X. Wang, T. Xu, F. Bai

e137

Re: Zhihua Lu, Guiting Lin, Amanda Reed-Maldonado, Chunxi Wang, Yung-Chin Lee, Tom F. Lue. Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis. Eur Urol 2017;71:223–33 Low-intensity Extracorporeal Shock Wave Treatment of Erectile Dysfunction: Does the Shadow Exceed the Light? http://dx.doi.org/10.1016/j.eururo.2016.09.018

C. Schulman, R. Virag, F. Montorsi

e139

Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317–24 Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception? http://dx.doi.org/10.1016/j.eururo.2016.09.034

U. Capitanio, A. Larcher, P. Dell’Oglio, F. Montorsi

e141

Re: Jaimin R. Bhatt, Patrick O. Richard, Nicole S. Kim, et al. Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4 cm Can Be Offered Active Surveillance as an Initial Management Strategy. Eur Urol 2016;70:85–90 http://dx.doi.org/10.1016/j.eururo.2016.10.014

Y. Cai, H. Li, Y. Zhang

e143

Re: Marco Borghesi, Hashim Ahmed, Robert Nam, et al. Complications After Systematic, Random, and Image-guided Prostate Biopsy. Eur Urol 2017;71:353–65 http://dx.doi.org/10.1016/j.eururo.2016.10.015

J. Grummet, L. Pepdjonovic, D. Moon

e145

Re: Scott P. Kelly, Philip S. Rosenberg, William F. Anderson, et al. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race. Eur Urol 2017;71:195–201 http://dx.doi.org/10.1016/j.eururo.2016.10.024

S.D. Brookman-May, M. May, S. Lebentrau, T. Klotz

e147

Re: Ernesto R. Cordeiro Feijoo, Arjun Sivaraman, Eric Barret, et al. Focal High- intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Eur Urol 2016;69:214–20 http://dx.doi.org/10.1016/j.eururo.2016.10.044

R. Yuan, H. Huang

e148

Reply to Runqiang Yuan and Hongxing Huang’s Letter to the Editor re: Ernesto R. Cordeiro Feijoo, Arjun Sivaraman, Eric Barret, et al. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Eur Urol 2016;69:214–20 http://dx.doi.org/10.1016/j.eururo.2017.01.034

A. Sivaraman, E. Barret

e u r o p e a n u r o l o g y , vo l . 7 1 , n o . 5 , Ma y 2 0 1 7

Letters to the Editor

published online

Research Letters